Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Reardon Andrew
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/14/2023
4
Reardon Andrew (CHIEF LEGAL OFFICER &) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns:
Paid exercise price by delivering 897 shares @ $68.73, valued at $61.7k
03/28/2023
4
Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2023
4
Reardon Andrew (See Remarks) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns:
Granted 5,668 shares @ $0
Granted 15,393 options to buy @ $75.09, valued at $1.2M
12/01/2022
4
Reardon Andrew (See Remarks) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns:
Paid exercise price by delivering 1,073 shares @ $72.9, valued at $78.2k
11/07/2022
3
Reardon Andrew (See Remarks) has filed a Form 3 on LIGAND PHARMACEUTICALS INC
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy